On November 9, INSILICO rose 5.39% in Regular Trading, trading at HK$39.72, with turnover of HK$117 million.
A clear catalyst is the company’s disclosed share repurchase, alongside broad strength across the Life Sciences Tools & Services sector.
INSILICO said it repurchased 400,000 shares on November 6 on-market at HK$36.921 to HK$38.30 per share, with an average repurchase price of about HK$37.5147 and total consideration of about HK$15.01 million. The buyback represents about 0.0681% of previously issued share capital and marks execution of the company’s previously authorized repurchase plan of up to HK$500 million. On the same date, the company also issued new shares tied to equity incentive exercises. In sector trading on November 9, WUXI BIO rose 5.0%, GENSCRIPT B-1K rose 4.67%, JOINN rose 4.04%, XTALPI rose 3.76%, and WUXI APPTEC rose 3.41%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments